Luc Truyen
Chief Tech/Sci/R&D Officer at ARGENX SE
Net worth: 644 878 $ as of 31/03/2024
Profile
Luc Truyen is currently the Chief Medical Officer at argenx SE.
Previously, he held positions as the Head of Research & Development at Johnson & Johnson Pharmaceutical Group and as the Chief Marketing Officer & Head of R&D at Janssen Alzheimer Immunotherapy.
Dr. Truyen obtained a doctorate degree from the University of Antwerp.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ARGEN-X SE
0.00% | 20/02/2024 | 1,631 ( 0.00% ) | 644 878 $ | 31/03/2024 |
Luc Truyen active positions
| Companies | Position | Start |
|---|---|---|
| ARGENX SE | Chief Tech/Sci/R&D Officer | 01/04/2022 |
Former positions of Luc Truyen
| Companies | Position | End |
|---|---|---|
| Johnson & Johnson Pharmaceutical Group | Chief Tech/Sci/R&D Officer | - |
| Janssen Alzheimer Immunotherapy | Sales & Marketing | - |
Training of Luc Truyen
| University of Antwerp | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ARGENX SE | Health Technology |
| Private companies | 2 |
|---|---|
| Johnson & Johnson Pharmaceutical Group | |
| Janssen Alzheimer Immunotherapy |
- Stock Market
- Insiders
- Luc Truyen
